Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Sep, 2017 | Pages:
118 | Publisher: JP Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global Antihistamine Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.
Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.
This report, with focus on top players in the global and Japan, studies the Antihistamine Drugs market's development status and future trend in the global and Japan. It splits Antihistamine Drugs market by type and by applications to fully and deeply research and reveal market profile and prospect.
The major players include
Akorn Pharmaceuticals (US)
Almirall S.A. (Spain)
Auctus Pharma Limited (India)
Bayer SA-NV (Belgium)
Kyowa Hakko Kirin Co.,Ltd. (Japan)
MEDA Pharma GmbH & Co. KG (Germany)
Merck Sharp & Dohme Limited (UK)
Nippon Boehringer Ingelheim Co.,Ltd. (Japan)
Pfizer Pharmaceutical Company (US)
Sanofi Winthrop Industries (France)
Santen Pharmaceutical Co.,Ltd. (Japan)
Schering-Plough Europe (US)
Sun Pharmaceutical Industries Ltd. (India)
Teva Pharmaceutical Industries (Israel)
Therabel Europe Limited (Ireland)
UCB Pharma GmbH (Germany)
Vintage Pharmaceuticals (US)
Geographically, this report splits the Global market into the following regions:
Asia Pacific
Japan
Tokyo
Yokohama
Osaka
Nagoya
Others
China
Korea
India
Others
Europe
France
Germany
United Kingdom
Italy
Russia
Others
North America
United States
Canada
Latin America
Brazil
Mexico
Others
Southeast Asia
Singapore
Malaysia
Vietnam
Myanmar
Thailand
Indonesia
Philippines
Others
Middle East & Africa
Saudi Arabia
Iran
UAE
Turkey
Israel
Egypt
South Africa
Others
On the basis of product, the Antihistamine Drugs market is primarily split into
By Antihistanmines
Azelastine
Brompheniramine
Carbinoxamine
Cetirizine
Other
By Access
Prescription
OTC
Key Applications
Department of respiration
Otolaryngology
Department of dermatology
Pharmacy
Table of Contents
2017-2022 Global and Japan Antihistamine Drugs Market Analysis Report
1 Antihistamine Drugs Overview
1.1 Product Overview and Scope of Antihistamine Drugs
1.2 Global and Japan Antihistamine Drugs Market by Applications/End Users
1.2.1 Japan Antihistamine Drugs Sales (K Units) and Market Share Comparison by Applications (2012-2017)
1.2.1.1 Japan Antihistamine Drugs Sales (K Units) and Market Share by Applications (2012-2017)
1.2.1.2 Japan Antihistamine Drugs Sales Growth Rate (%) by Applications (2012-2017)
1.2.1.3 Market Drivers and Opportunities
1.2.2 Japan Antihistamine Drugs Sales (K Units) and Market Share Comparison by Applications (2012-2017)
1.2.3 Global Antihistamine Drugs Sales by Application (2012-2017)
1.2.3.1 Global Antihistamine Drugs Sales (K Units) and Market Share by Applications (2012-2017)
1.2.3.2 Global Antihistamine Drugs Sales Growth Rate (%) by Applications (2012-2017)
1.2.3.3 Market Drivers and Opportunities
1.2.4 Global Antihistamine Drugs Sales (K Units) and Market Share Comparison by Applications (2012-2017)
1.2.5 Department of respiration
1.2.6 Otolaryngology
1.2.7 Department of dermatology
1.2.8 Pharmacy
1.3 Global and Japan Market Size (Sales and Revenue) of Antihistamine Drugs (2012-2017)
1.3.1 Japan Market Size (Sales and Revenue) of Antihistamine Drugs (2012-2017)
1.3.1.1 Japan Antihistamine Drugs Sales (K Units) and Growth Rate (%) (2012-2017)
1.3.1.2 Japan Antihistamine Drugs Revenue (Million USD) and Growth Rate (2012-2017)
1.3.2 Global Market Size (Sales and Revenue) of Antihistamine Drugs (2012-2017)
1.3.2.1 Global Antihistamine Drugs Sales (K Units) and Growth Rate (%) (2012-2017)
1.3.2.2 Global Antihistamine Drugs Revenue (Million USD) and Growth Rate (2012-2017)
1.4 Global and Japan Classification of Antihistamine Drugs by Antihistanmines
1.4.1 Japan Antihistamine Drugs Sales (K Units) and Market Share by Antihistanmines (2012-2017)
1.4.2 Global Antihistamine Drugs Sales (K Units) and Market Share by Antihistanmines (2012-2017)
1.4.3 Japan Antihistamine Drugs Revenue (Million USD) and Market Share by Antihistanmines (2012-2017)
1.4.4 Global Antihistamine Drugs Revenue (Million USD) and Market Share by Antihistanmines (2012-2017)
1.4.5 Japan Antihistamine Drugs Price (USD/Unit) by Antihistanmines (2012-2017)
1.4.6 Global Antihistamine Drugs Price (USD/Unit) by Antihistanmines (2012-2017)
1.4.7 Japan Antihistamine Drugs Sales Growth Rate (%) by Antihistanmines (2012-2017)
1.4.8 Global Antihistamine Drugs Sales Growth Rate (%) by Antihistanmines (2012-2017)
1.4.9 Azelastine
1.4.10 Brompheniramine
1.4.11 Carbinoxamine
1.4.12 Cetirizine
1.4.13 Other
1.5 Global and Japan Classification of Antihistamine Drugs by Access
1.5.1 Japan Antihistamine Drugs Sales (K Units) and Market Share by Access (2012-2017)
1.5.2 Global Antihistamine Drugs Sales (K Units) and Market Share by Access (2012-2017)
1.5.3 Japan Antihistamine Drugs Revenue (Million USD) and Market Share by Access (2012-2017)
1.5.4 Global Antihistamine Drugs Revenue (Million USD) and Market Share by Access (2012-2017)
1.5.5 Japan Antihistamine Drugs Price (USD/Unit) by Access (2012-2017)
1.5.6 Global Antihistamine Drugs Price (USD/Unit) by Access (2012-2017)
1.5.7 Japan Antihistamine Drugs Sales Growth Rate (%) by Access (2012-2017)
1.5.8 Global Antihistamine Drugs Sales Growth Rate (%) by Access (2012-2017)
1.5.9 Prescription
1.5.10 OTC
2 Global and Japan Antihistamine Drugs Market Competition by Players/Manufacturers
2.1 Japan Antihistamine Drugs Market Competition by Players/Manufacturers
2.1.1 Japan Antihistamine Drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.1.2 Japan Antihistamine Drugs Revenue and Share by Players/Manufacturers (2012-2017)
2.1.3 Japan Antihistamine Drugs Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.1.4 Japan Antihistamine Drugs Market Competitive Situation and Trends
2.1.4.1 Japan Antihistamine Drugs Market Concentration Rate
2.1.4.2 Japan Antihistamine Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
2.1.5 Japan Players/Manufacturers Antihistamine Drugs Manufacturing Base Distribution, Sales Area, Product Types
2.2 Global Antihistamine Drugs Market Competition by Players/Manufacturers
2.2.1 Global Antihistamine Drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2.2 Global Antihistamine Drugs Revenue and Share by Players/Manufacturers (2012-2017)
2.2.3 Global Antihistamine Drugs Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.2.4 Global Antihistamine Drugs Market Competitive Situation and Trends
2.2.4.1 Global Antihistamine Drugs Market Concentration Rate
2.2.4.2 Global Antihistamine Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
2.2.5 Global Players/Manufacturers Antihistamine Drugs Manufacturing Base Distribution, Sales Area, Product Types
3 Global and Japan Antihistamine Drugs Sales and Revenue by Regions (2012-2017)
3.1 Asia Pacific Antihistamine Drugs Sales and Revenue by Regions (2012-2017)
3.1.1 Japan Antihistamine Drugs Sales and Revenue (2012-2017)
3.1.1.1 Japan Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.1.1.2 Japan Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.1.1.3 Japan Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.1.2 China Antihistamine Drugs Sales and Revenue (2012-2017)
3.1.2.1 China Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.1.2.2 China Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.1.2.3 China Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.1.3 Korea Antihistamine Drugs Sales and Revenue (2012-2017)
3.1.3.1 Korea Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.1.3.2 Korea Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.1.3.3 Korea Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.1.4 India Antihistamine Drugs Sales and Revenue (2012-2017)
3.1.4.1 India Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.1.4.2 India Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.1.4.3 India Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.1.5 Others Antihistamine Drugs Sales and Revenue (2012-2017)
3.1.5.1 Others Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.1.5.2 Others Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.1.5.3 Others Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.2 Europe Antihistamine Drugs Sales and Revenue by Regions (2012-2017)
3.2.1 France Antihistamine Drugs Sales and Revenue (2012-2017)
3.2.1.1 France Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.2.1.2 France Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.2.1.3 France Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.2.2 Germany Antihistamine Drugs Sales and Revenue (2012-2017)
3.2.2.1 Germany Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.2.2.2 Germany Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.2.2.3 Germany Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.2.3 United Kingdom Antihistamine Drugs Sales and Revenue (2012-2017)
3.2.3.1 United Kingdom Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.2.3.2 United Kingdom Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.2.3.3 United Kingdom Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.2.4 Italy Antihistamine Drugs Sales and Revenue (2012-2017)
3.2.4.1 Italy Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.2.4.2 Italy Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.2.4.3 Italy Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.2.5 Russia Antihistamine Drugs Sales and Revenue (2012-2017)
3.2.5.1 Russia Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.2.5.2 Russia Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.2.5.3 Russia Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.2.6 Others Antihistamine Drugs Sales and Revenue (2012-2017)
3.2.6.1 Others Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.2.6.2 Others Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.2.6.3 Others Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.3 North America Antihistamine Drugs Sales and Revenue by Regions (2012-2017)
3.3.1 United States Antihistamine Drugs Sales and Revenue (2012-2017)
3.3.1.1 United States Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.3.1.2 United States Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.3.1.3 United States Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.3.2 Canada Antihistamine Drugs Sales and Revenue (2012-2017)
3.3.2.1 Canada Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.3.2.2 Canada Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.3.2.3 Canada Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.4 Latin America Antihistamine Drugs Sales and Revenue by Regions (2012-2017)
3.4.1 Brazil Antihistamine Drugs Sales and Revenue (2012-2017)
3.4.1.1 Brazil Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.4.1.2 Brazil Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.4.1.3 Brazil Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.4.2 Mexico Antihistamine Drugs Sales and Revenue (2012-2017)
3.4.2.1 Mexico Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.4.2.2 Mexico Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.4.2.3 Mexico Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.4.3 Others Antihistamine Drugs Sales and Revenue (2012-2017)
3.4.3.1 Others Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.4.3.2 Others Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.4.3.3 Others Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.5 Southeast Asia Antihistamine Drugs Sales and Revenue by Regions (2012-2017)
3.5.1 Singapore Antihistamine Drugs Sales and Revenue (2012-2017)
3.5.1.1 Singapore Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.5.1.2 Singapore Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.5.1.3 Singapore Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.5.2 Malaysia Antihistamine Drugs Sales and Revenue (2012-2017)
3.5.2.1 Malaysia Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.5.2.2 Malaysia Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.5.2.3 Malaysia Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.5.3 Vietnam Antihistamine Drugs Sales and Revenue (2012-2017)
3.5.3.1 Vietnam Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.5.3.2 Vietnam Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.5.3.3 Vietnam Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.5.4 Myanmar Antihistamine Drugs Sales and Revenue (2012-2017)
3.5.4.1 Myanmar Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.5.4.2 Myanmar Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.5.4.3 Myanmar Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.5.5 Thailand Antihistamine Drugs Sales and Revenue (2012-2017)
3.5.5.1 Thailand Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.5.5.2 Thailand Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.5.5.3 Thailand Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.5.6 Indonesia Antihistamine Drugs Sales and Revenue (2012-2017)
3.5.6.1 Indonesia Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.5.6.2 Indonesia Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.5.6.3 Indonesia Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.5.7 Philippines Antihistamine Drugs Sales and Revenue (2012-2017)
3.5.7.1 Philippines Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.5.7.2 Philippines Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.5.7.3 Philippines Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.5.8 Others Antihistamine Drugs Sales and Revenue (2012-2017)
3.5.8.1 Others Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.5.8.2 Others Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.5.8.3 Others Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.6 Middle East & Africa Antihistamine Drugs Sales and Revenue by Regions (2012-2017)
3.6.1 Saudi Arabia Antihistamine Drugs Sales and Revenue (2012-2017)
3.6.1.1 Saudi Arabia Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.6.1.2 Saudi Arabia Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.6.1.3 Saudi Arabia Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.6.2 Iran Antihistamine Drugs Sales and Revenue (2012-2017)
3.6.2.1 Iran Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.6.2.2 Iran Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.6.2.3 Iran Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.6.3 UAE Antihistamine Drugs Sales and Revenue (2012-2017)
3.6.3.1 UAE Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.6.3.2 UAE Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.6.3.3 UAE Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.6.4 Turkey Antihistamine Drugs Sales and Revenue (2012-2017)
3.6.4.1 Turkey Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.6.4.2 Turkey Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.6.4.3 Turkey Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.6.5 Israel Antihistamine Drugs Sales and Revenue (2012-2017)
3.6.5.1 Israel Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.6.5.2 Israel Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.6.5.3 Israel Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.6.6 Egypt Antihistamine Drugs Sales and Revenue (2012-2017)
3.6.6.1 Egypt Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.6.6.2 Egypt Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.6.6.3 Egypt Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.6.7 South Africa Antihistamine Drugs Sales and Revenue (2012-2017)
3.6.7.1 South Africa Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.6.7.2 South Africa Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.6.7.3 South Africa Antihistamine Drugs Price (USD/Unit)(2012-2017)
3.6.8 Others Antihistamine Drugs Sales and Revenue (2012-2017)
3.6.8.1 Others Antihistamine Drugs Sales (K Units) and Market Share (2012-2017)
3.6.8.2 Others Antihistamine Drugs Revenue (Million USD) and Market Share (2012-2017)
3.6.8.3 Others Antihistamine Drugs Price (USD/Unit)(2012-2017)
4 Global and Japan Antihistamine Drugs Players/Manufacturers Profiles and Sales Data
4.1 Akorn Pharmaceuticals (US)
4.1.1 Company Basic Information, Manufacturing Base and Competitors
4.1.2 Antihistamine Drugs Product Category, Application and Specification
4.1.2.1 Product A
4.1.2.2 Product B
4.1.3 Akorn Pharmaceuticals (US) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.1.4 Main Business/Business Overview
4.2 Almirall S.A. (Spain)
4.2.1 Company Basic Information, Manufacturing Base and Competitors
4.2.2 Antihistamine Drugs Product Category, Application and Specification
4.2.2.1 Product A
4.2.2.2 Product B
4.2.3 Almirall S.A. (Spain) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.2.4 Main Business/Business Overview
4.3 Auctus Pharma Limited (India)
4.3.1 Company Basic Information, Manufacturing Base and Competitors
4.3.2 Antihistamine Drugs Product Category, Application and Specification
4.3.2.1 Product A
4.3.2.2 Product B
4.3.3 Auctus Pharma Limited (India) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.3.4 Main Business/Business Overview
4.4 Bayer SA-NV (Belgium)
4.4.1 Company Basic Information, Manufacturing Base and Competitors
4.4.2 Antihistamine Drugs Product Category, Application and Specification
4.4.2.1 Product A
4.4.2.2 Product B
4.4.3 Bayer SA-NV (Belgium) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.4.4 Main Business/Business Overview
4.5 Kyowa Hakko Kirin Co.,Ltd. (Japan)
4.5.1 Company Basic Information, Manufacturing Base and Competitors
4.5.2 Antihistamine Drugs Product Category, Application and Specification
4.5.2.1 Product A
4.5.2.2 Product B
4.5.3 Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.5.4 Main Business/Business Overview
4.6 MEDA Pharma GmbH & Co. KG (Germany)
4.6.1 Company Basic Information, Manufacturing Base and Competitors
4.6.2 Antihistamine Drugs Product Category, Application and Specification
4.6.2.1 Product A
4.6.2.2 Product B
4.6.3 MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.6.4 Main Business/Business Overview
4.7 Merck Sharp & Dohme Limited (UK)
4.7.1 Company Basic Information, Manufacturing Base and Competitors
4.7.2 Antihistamine Drugs Product Category, Application and Specification
4.7.2.1 Product A
4.7.2.2 Product B
4.7.3 Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.7.4 Main Business/Business Overview
4.8 Nippon Boehringer Ingelheim Co.,Ltd. (Japan)
4.8.1 Company Basic Information, Manufacturing Base and Competitors
4.8.2 Antihistamine Drugs Product Category, Application and Specification
4.8.2.1 Product A
4.8.2.2 Product B
4.8.3 Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.8.4 Main Business/Business Overview
4.9 Pfizer Pharmaceutical Company (US)
4.9.1 Company Basic Information, Manufacturing Base and Competitors
4.9.2 Antihistamine Drugs Product Category, Application and Specification
4.9.2.1 Product A
4.9.2.2 Product B
4.9.3 Pfizer Pharmaceutical Company (US) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.9.4 Main Business/Business Overview
4.10 Sanofi Winthrop Industries (France)
4.10.1 Company Basic Information, Manufacturing Base and Competitors
4.10.2 Antihistamine Drugs Product Category, Application and Specification
4.10.2.1 Product A
4.10.2.2 Product B
4.10.3 Sanofi Winthrop Industries (France) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
4.10.4 Main Business/Business Overview
4.11 Santen Pharmaceutical Co.,Ltd. (Japan)
4.12 Schering-Plough Europe (US)
4.13 Sun Pharmaceutical Industries Ltd. (India)
4.14 Teva Pharmaceutical Industries (Israel)
4.15 Therabel Europe Limited (Ireland)
4.16 UCB Pharma GmbH (Germany)
4.17 Vintage Pharmaceuticals (US)
5 Antihistamine Drugs Manufacturing Cost Analysis
5.1 Antihistamine Drugs Key Raw Materials Analysis
5.1.1 Key Raw Materials
5.1.2 Price Trend of Key Raw Materials
5.1.3 Key Suppliers of Raw Materials
5.1.4 Market Concentration Rate of Raw Materials
5.2 Proportion of Manufacturing Cost Structure
5.2.1 Raw Materials
5.2.2 Labor Cost
5.2.3 Manufacturing Expenses
5.3 Manufacturing Process Analysis of Antihistamine Drugs
6 Industrial Chain, Sourcing Strategy and Downstream Buyers
6.1 Antihistamine Drugs Industrial Chain Analysis
6.2 Upstream Raw Materials Sourcing
6.3 Raw Materials Sources of Antihistamine Drugs Major Players/Manufacturers in 2016
6.4 Downstream Buyers
7 Marketing Strategy Analysis, Distributors/Traders
7.1 Marketing Channel
7.1.1 Direct Marketing
7.1.2 Indirect Marketing
7.1.3 Marketing Channel Development Trend
7.2 Market Positioning
7.2.1 Pricing Strategy
7.2.2 Brand Strategy
7.2.3 Target Client
7.3 Distributors/Traders List
8 Market Effect Factors Analysis
8.1 Technology Progress/Risk
8.1.1 Substitutes Threat
8.1.2 Technology Progress in Related Industry
8.2 Consumer Needs/Customer Preference Change
8.3 Economic/Political Environmental Change
9 Global and Japan Antihistamine Drugs Market Size (Sales and Revenue) Forecast (2017-2022)
9.1 Global and Japan Antihistamine Drugs Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
9.2 Global and Japan Antihistamine Drugs Sales (K Units) Forecast by Type (2017-2022)
9.2.1 by Antihistanmines
9.2.2 by Access
9.3 Global and Japan Antihistamine Drugs Sales (K Units) Forecast by Application (2017-2022)
9.4 Global and Japan Antihistamine Drugs Sales (K Units) Forecast by Regions (2017-2022)
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Disclaimer
11.4 Author List
List of Tables and Figures
Figure Product Picture of Antihistamine Drugs
Table Japan Antihistamine Drugs Sales (Million Units) Comparison by Applications (2012-2017)
Figure Japan Sales Market Share (%) of Antihistamine Drugs by Applications in 2016
Table Global Antihistamine Drugs Sales (Million Units) Comparison by Applications (2012-2017)
Figure Global Sales Market Share (%) of Antihistamine Drugs by Applications in 2016
Figure Department of respiration Examples
Table Key Downstream Customer in Department of respiration
Figure Otolaryngology Examples
Table Key Downstream Customer in Otolaryngology
Figure Department of dermatology Examples
Table Key Downstream Customer in Department of dermatology
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure Azelastine Product Picture
Figure Brompheniramine Product Picture
Figure Carbinoxamine Product Picture
Figure Cetirizine Product Picture
Figure Other Product Picture
Figure Prescription Product Picture
Figure OTC Product Picture
Table Akorn Pharmaceuticals (US) Basic Information List
Table Akorn Pharmaceuticals (US) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Akorn Pharmaceuticals (US) Antihistamine Drugs Sales Growth Rate (%)(2012-2017)
Table Akorn Pharmaceuticals (US) Antihistamine Drugs Sales Market Share (%) in Japan (2012-2017)
Figure Akorn Pharmaceuticals (US) Antihistamine Drugs Revenue Market Share (%) in Japan (2012-2017)
Table Almirall S.A. (Spain) Basic Information List
Table Almirall S.A. (Spain) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Almirall S.A. (Spain) Antihistamine Drugs Sales Growth Rate (%)(2012-2017)
Table Almirall S.A. (Spain) Antihistamine Drugs Sales Market Share (%) in Japan (2012-2017)
Figure Almirall S.A. (Spain) Antihistamine Drugs Revenue Market Share (%) in Japan (2012-2017)
Table Auctus Pharma Limited (India) Basic Information List
Table Auctus Pharma Limited (India) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Auctus Pharma Limited (India) Antihistamine Drugs Sales Growth Rate (%)(2012-2017)
Table Auctus Pharma Limited (India) Antihistamine Drugs Sales Market Share (%) in Japan (2012-2017)
Figure Auctus Pharma Limited (India) Antihistamine Drugs Revenue Market Share (%) in Japan (2012-2017)
Table Bayer SA-NV (Belgium) Basic Information List
Table Bayer SA-NV (Belgium) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Bayer SA-NV (Belgium) Antihistamine Drugs Sales Growth Rate (%)(2012-2017)
Table Bayer SA-NV (Belgium) Antihistamine Drugs Sales Market Share (%) in Japan (2012-2017)
Figure Bayer SA-NV (Belgium) Antihistamine Drugs Revenue Market Share (%) in Japan (2012-2017)
Table Kyowa Hakko Kirin Co.,Ltd. (Japan) Basic Information List
Table Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Sales Growth Rate (%)(2012-2017)
Table Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Sales Market Share (%) in Japan (2012-2017)
Figure Kyowa Hakko Kirin Co.,Ltd. (Japan) Antihistamine Drugs Revenue Market Share (%) in Japan (2012-2017)
Table MEDA Pharma GmbH & Co. KG (Germany) Basic Information List
Table MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Sales Growth Rate (%)(2012-2017)
Table MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Sales Market Share (%) in Japan (2012-2017)
Figure MEDA Pharma GmbH & Co. KG (Germany) Antihistamine Drugs Revenue Market Share (%) in Japan (2012-2017)
Table Merck Sharp & Dohme Limited (UK) Basic Information List
Table Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Sales Growth Rate (%)(2012-2017)
Table Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Sales Market Share (%) in Japan (2012-2017)
Figure Merck Sharp & Dohme Limited (UK) Antihistamine Drugs Revenue Market Share (%) in Japan (2012-2017)
Table Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Basic Information List
Table Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Sales Growth Rate (%)(2012-2017)
Table Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Sales Market Share (%) in Japan (2012-2017)
Figure Nippon Boehringer Ingelheim Co.,Ltd. (Japan) Antihistamine Drugs Revenue Market Share (%) in Japan (2012-2017)
Table Pfizer Pharmaceutical Company (US) Basic Information List
Table Pfizer Pharmaceutical Company (US) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Pfizer Pharmaceutical Company (US) Antihistamine Drugs Sales Growth Rate (%)(2012-2017)
Table Pfizer Pharmaceutical Company (US) Antihistamine Drugs Sales Market Share (%) in Japan (2012-2017)
Figure Pfizer Pharmaceutical Company (US) Antihistamine Drugs Revenue Market Share (%) in Japan (2012-2017)
Table Sanofi Winthrop Industries (France) Basic Information List
Table Sanofi Winthrop Industries (France) Antihistamine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Sanofi Winthrop Industries (France) Antihistamine Drugs Sales Growth Rate (%)(2012-2017)
Table Sanofi Winthrop Industries (France) Antihistamine Drugs Sales Market Share (%) in Japan (2012-2017)
Figure Sanofi Winthrop Industries (France) Antihistamine Drugs Revenue Market Share (%) in Japan (2012-2017)
Table Santen Pharmaceutical Co.,Ltd. (Japan) Basic Information List
Table Schering-Plough Europe (US) Basic Information List
Table Sun Pharmaceutical Industries Ltd. (India) Basic Information List
Table Teva Pharmaceutical Industries (Israel) Basic Information List
Table Therabel Europe Limited (Ireland) Basic Information List
Table UCB Pharma GmbH (Germany) Basic Information List
Table Vintage Pharmaceuticals (US) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antihistamine Drugs
Figure Manufacturing Process Analysis of Antihistamine Drugs
Figure Antihistamine Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antihistamine Drugs Major Players/Manufacturers in 2016
Table Major Buyers of Antihistamine Drugs
Table Distributors/Traders List
Figure Japan Antihistamine Drugs Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Japan Antihistamine Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Antihistamine Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Figure Global Antihistamine Drugs Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global Antihistamine Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Antihistamine Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table Japan Antihistamine Drugs Sales (K Units) Forecast by Type (2017-2022)
Table Global Antihistamine Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Japan Antihistamine Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Global Antihistamine Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Japan Antihistamine Drugs Sales Volume Market Share Forecast by Type in 2017
Figure Global Antihistamine Drugs Sales Volume Market Share Forecast by Type in 2017
Table Japan Antihistamine Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Japan Antihistamine Drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Japan Antihistamine Drugs Sales Volume Market Share Forecast by Application in 2017
Table Global Antihistamine Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Global Antihistamine Drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Antihistamine Drugs Sales Volume Market Share Forecast by Application in 2017
Table Japan Antihistamine Drugs Sales (K Units) Forecast by Regions (2017-2022)
Table Japan Antihistamine Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Japan Antihistamine Drugs Sales Volume Share Forecast by Regions (2017-2022)
Table Global Antihistamine Drugs Sales (K Units) Forecast by Regions (2017-2022)
Table Global Antihistamine Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Antihistamine Drugs Sales Volume Share Forecast by Regions (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
